Non erythropoietic effects of Erythropoietin

Chiara Guglielmo, Chiara Cantarelli, Andrea Angeletti, Paola Todeschini, Paolo Cravedi

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations


Over the past two decades it has emerged that, in addition to erythropoietic activity, erythropoietin (EPO) has numerous other functions, including neuro-protective, anti-apoptotic, antioxidant, angiogenetic and immunomodulatory ones. EPO interacts with two different forms of its receptor (EPOR): a homodimer receptor, responsible for the erythropoietic effects, and a heterodimer receptor, responsible for the non-erythropoietic effects. The effects on the heterodimer receptor are responsible for EPO-induced prolongation of organ transplant survival in mice and humans. The development of new molecules that selectively target the heterodimer EPOR is allowing to test the effect of long-term treatments, without the possible complications related to the increased hematocrit.

Original languageEnglish
JournalGiornale italiano di nefrologia : organo ufficiale della Società italiana di nefrologia
Issue number5
StatePublished - 24 Sep 2019


  • ARA290
  • EPO
  • EPOR
  • erythropoietin


Dive into the research topics of 'Non erythropoietic effects of Erythropoietin'. Together they form a unique fingerprint.

Cite this